07 April 2023 : Original article
Postoperative Outcomes in 415 Patients Following Liver Transplantation Using Extended Donor Criteria: A Study from a Single Center in Germany
Aladdin Ali Deeb1ACE*, Utz Settmacher1D, Johannes Fritsch1BC, Felix Dondorf1AD, Oliver Rohland1F, Falk Rauchfuß1DEDOI: 10.12659/AOT.939060
Ann Transplant 2023; 28:e939060
Table 1 Demographic results of all 415 included recipients.
| Age (years) | Median 58, (range 25 to 76) |
|---|---|
| Sex | Male 301 (72.5%), female 114 (27.5%) |
| Weight (kg) | Median 80, (range 33 to 135) |
| Hight (cm) | Median 172, (range 146 to 194) |
| BMI (kg/m) | Median 27.4, (range 14.5 to 41.5) |
| Listing diagnosis | |
| Alcoholic cirrhosis | 229 (55.2%) |
| HCC | 142 (34.2) |
| Autoimmune diseases | 29 (7%) |
| Viral hepatitis | 30 (7.2%) |
| Polycystic liver degeneration | 17 (4.1%) |
| Idiopathic cirrhosis | 42 (10.1%) |
| Others | 38 (9.2%) |
| MELD | N=293 (70.6%), median 17, (range 6 to 40) |
| Exceptional MELD | N=122 (29.4%), median 28, (range 18 to 40) |
| Time to transplantation (days) | Median 159, (range 0 to 4685) |
| BMI – body mass index; HCC – hepatocellular carcinoma. Autoimmune diseases: primary sclerosing cholangitis, primary biliary cirrhosis, autoimmune hepatitis. Others: drug induced liver failure, other malignancies except HCC; metastases from neuroendocrine tumors, cholangiocellular carcinoma (CCC), haemochromatosis. MELD – Model for End-Stage Liver Disease. | |